PuraPharm Corporation Limited announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was HKD 333.558 million compared to HKD 386.604 million a year ago. Net loss was HKD 45.180 million compared to net income of HKD 13.348 million a year ago. Basic loss per share was HKD 0.184 compared to basic earnings per share of HKD 0.055 a year ago. Diluted loss per share was HKD 0.184 compared to diluted earnings per share of HKD 0.054 a year ago.